Smoking cessation among adults with substance use problems with Olufemi Erinoso and Jennifer Pearson

Smoking cessation among adults with substance use problems with Olufemi Erinoso and Jennifer Pearson

In this episode, Dr Zoe Swithenbank speaks to Dr Olufemi Erinoso, a postdoctoral fellow at the Massachusetts General Hospital and Dr Jennifer Pearson, an Associate Professor in the School of Public Health at the University of Nevada, Reno. The interview covers Olufemi and Jennifer’s research article covering the use of cessation products, e-cigarettes, and cigarette cessation outcomes among adults with substance use problems, using the Population Assessment of Tobacco and Health (PATH) Study from 2013-2021.

  • An overview of the study [01:35]
  • The key findings of the study [02:44]
  • The unexpected findings [05:57]
  • Considerations of the tobacco and e-cigarette policy context throughout the study period [08:02]
  • Variations in findings across race/ethnicity [11:10]
  • Policy recommendations for what works with regards to smoking cessation [13:38]
  • The big take away from the study [15:30]

About Zoe Swithenbank: Zoe is a senior research associate at Lancaster University, currently working on a National Institute for Health and Care Research (NIHR) funded research project exploring treatment pathways for co-occurring alcohol and mental health problems. She recently completed her PhD at Liverpool John Moores University on behavioural interventions for smoking cessation in substance use treatment services. Prior to starting her academic career, Zoe worked in health services including substance use, mental health, and homeless services, and these experiences shaped her research interests, as well as her commitment to the inclusion of people with lived experience in research.

About Olufemi Erinoso: Olufemi, PhD, MPH, BDS, is a public health researcher and clinician-scientist specializing in tobacco control, harm reduction, and health systems research. He earned his MPH from Johns Hopkins Bloomberg School of Public Health and PhD in Public Health (Social and Behavioral Health) from the University of Nevada, Reno, followed by postdoctoral training at Massachusetts General Hospital. His research addresses electronic nicotine delivery systems, substance use, and implementation science, with extensive experience analyzing large population-based datasets. Olufemi has authored over 50 peer-reviewed publications in leading journals and advances national and global tobacco regulatory science.

About Jennifer Pearson: Jennifer is an Associate Professor in the Department of Health Behavior, Policy, and Administration Sciences in the School of Public Health at the University of Nevada, Reno. Broadly, her research focuses on how regulation of tobacco and cannabis product characteristics, packaging, and advertising affects consumer behavior and public health outcomes. Jennifer has authored over 140 scientific peer-reviewed scientific articles on tobacco and cannabis policy and published in high-impact journals such as the Addiction, the American Journal of Public Health, and Tobacco Control. Dr. Pearson earned her doctorate in Social and Behavioral Health from the Johns Hopkins Bloomberg School of Public Health in 2011, and her Master of Public Health degree from George Washington University in 2007. Jennifer started her career in public health as a Tobacco Education Coordinator for the American Lung Association of Nevada and served as a US Peace Corps volunteer in Guinea from 2002-2004.

Original article: Use of cessation products, e-cigarettes and cigarette cessation outcomes among adults with substance use problems: Results from 2013–2021 (Waves 1–6) of the Population Assessment of Tobacco and Health (PATH) Study https://doi.org/10.1111/add.70098

The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.


Hosted on Acast. See acast.com/privacy for more information.

Avsnitt(126)

Opioids, cancer and mortality with Aleksi Hamina

Opioids, cancer and mortality with Aleksi Hamina

In this episode Ben Scher talks to Dr Aleksi Hamina from the Norwegian centre for addiction research at the University of Oslo and the Niuvanniemi Hospital in Finland. They discuss a recent paper co-a...

18 Juli 202413min

Cannabis potency and psychotic experiences with Lindsey Hines

Cannabis potency and psychotic experiences with Lindsey Hines

In this episode, Dr Rob Calder talks to Dr Lindsey Hines about her study using longitudinal data to examine links between cannabis use, cannabis potency and psychotic experiences. Dr Hines talks about...

6 Juni 202425min

Cannabis use in the US with Jonathan Caulkins

Cannabis use in the US with Jonathan Caulkins

In this episode Dr Elle Wadsworth talks to Professor Jonathan Caulkins about self-reported cannabis use in the US between 1979 and 2022 and how those trends compare with alcohol use over the same peri...

22 Maj 202422min

Integrated care vans with Kathleen Page

Integrated care vans with Kathleen Page

In this episode, Ben Scher talks to Dr Kathleen Page about her evaluation of an integrated care van that ran in Baltimore offering healthcare interventions and buprenorphine prescribing. Dr Page discu...

9 Maj 202426min

Smoking and abdominal obesity with Germán Carrasquilla

Smoking and abdominal obesity with Germán Carrasquilla

In this episode Rob Calder talks to Dr Germán Carrasquilla about his study assessing whether smoking cased increases in abdominal obesity or belly fat. They discuss the implications of this kind of fa...

2 Maj 202417min

Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith

Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith

In this episode Ben Scher talks to Dr Adam Bakker, Professor Michael Liebrenz and Dr Alexander Smith about their commentary in response to a previous paper by Domzaridou and colleages (2023). They dis...

25 Apr 202423min

Contingency management with Gabriela Khazanov, James, McKay and Richard Rawson

Contingency management with Gabriela Khazanov, James, McKay and Richard Rawson

In this episode, Ben Scher talks to Dr Gabriela Khazanov, Professor James McKay and Professor Richard Rawson. They discuss what contingency management is and how effective it can be in treatment setti...

17 Apr 202427min

Xylazine, heroin and drug markets with Caroline Copeland

Xylazine, heroin and drug markets with Caroline Copeland

In this episode Ben Scher talks to Dr Caroline Copeland about her work analysing drug death data to identify drug use trends, harms and to inform policy. Caroline talks about how xylazine first entere...

9 Apr 202420min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
det-morka-psyket
rss-ufo-bortom-rimligt-tvivel-2
rss-spraket
svd-nyhetsartiklar
rss-vetenskapsradion-2
medicinvetarna
rss-vetenskapsradion
bildningspodden
sexet
paranormalt-med-caroline-giertz
dumforklarat
halsorevolutionen
hacka-livet
rss-odla
vetenskapsradion
rss-tidslinjen-podcast